Paramount Skydance Corp Class B Peer Comparison
$10.27
$-0.36
(-3.34%)
As on 18-Sep-2026 13:38EDT
Market cap
$11,893 Mln
Revenue (TTM)
$29,432 Mln
P/E Ratio
353.3
P/B Ratio
1
Div. Yield
1.9 %
Edit
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
Market cap ($ Mln) |
11,893 | 248,407 | 1,233 | 181,906 |
Revenue ($ Mln) |
29,432 | 61,366 | 57,743 | 98,861 |
Net Profit ($ Mln) |
-621.00 | 10,446.00 | -8,956.01 | 8,600.00 |
Net Margin (%) |
-2.11 | 17.02 | -15.51 | 8.70 |
RoE (%) |
-5.35 | 21.11 | -9.71 | 7.29 |
Price to Earnings |
353.33 | 23.91 | -- | 22.09 |
Price-To-Book |
0.99 | 4.92 | 0.19 | 1.68 |
Income Statement ($ Mln)
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
|
Operating Revenue
|
29,432.00 | 61,366.00 | 57,743.08 | 98,861.00 |
|
Cost of Revenue
|
20,970.00 | 11,120.00 | 35,610.38 | 61,694.00 |
|
Gross Profit
|
9,776.00 | 48,106.00 | 22,483.42 | 35,659.00 |
|
Operating Expenses
|
20,142.00 | 36,275.00 | 15,948.22 | 21,345.00 |
|
Operating Profit (EBIT)
|
-5,430.00 | 13,971.00 | 6,184.48 | 15,822.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-6,004.00 | 12,586.00 | -73.72 | 12,750.00 |
|
Provision for Tax
|
-5,841.00 | 2,133.00 | 8,355.90 | 3,514.00 |
|
Profit after Tax (Net Income)
|
-621.00 | 10,446.00 | -8,956.01 | 8,600.00 |
|
Minority Interest
|
-7.00 | -7.00 | -528.76 | -636.00 |
|
Consolidated Profit
|
0.00 | 4,859.00 | -9,962.53 | 3,715.00 |
Liabilities ($ Mln)
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
|
Shareholder's Funds
|
11,771.00 | 50,236.26 | 101,822.30 | 110,032.00 |
|
Minority Interest
|
-7.00 | -7.00 | -528.76 | -636.00 |
|
Non-Current Liabilities
|
21,001.00 | 33,870.40 | 96,959.00 | 52,793.00 |
|
Current Liabilities
|
10,600.00 | 31,516.15 | 27,246.40 | 35,105.00 |
|
Total Liabilities
|
43,342.00 | 114,074.00 | 229,262.20 | 197,514.00 |
Assets ($ Mln)
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
|
Non-Current Assets
|
33,391.00 | 87,765.39 | 170,498.90 | 179,848.00 |
|
Current Assets
|
11,020.00 | 27,932.34 | 65,362.20 | 24,892.00 |
|
Total Assets
|
43,342.00 | 114,074.00 | 229,262.20 | 197,514.00 |
|
Total Debt*
|
15,156.00 | 32,201.35 | 87,811.60 | 46,041.00 |
|
Net Current Assets
|
420.00 | -3,588.00 | 38,115.80 | -10,213.00 |
Cashflow ($ Mln)
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
|
Cash From Operating Activities
|
485.00 | 14,575.00 | 23,195.21 | 18,101.00 |
|
Cash Flow from Investing Activities
|
-160.00 | -6,808.00 | -16,624.48 | -8,043.00 |
|
Cash from Financing Activities
|
-911.00 | -7,544.00 | -16,321.25 | -10,366.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- |
Ratios
Profitability Ratios
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
|
ROCE (%)
|
-21.11 | 13.74 | -4.63 | 8.12 |
|
ROE (%)
|
-5.35 | 21.11 | -9.71 | 7.29 |
|
ROA (%)
|
-1.14 | 7.13 | -3.40 | 3.66 |
|
EBIT Margin (%)
|
-16.85 | 23.34 | 16.14 | 17.90 |
|
Net Margin (%)
|
-2.11 | 17.02 | -15.51 | 8.70 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
|
Revenue Growth (%)
|
2.35 | 8.61 | -4.23 | 4.58 |
|
EBIT Growth (%)
|
-461.44 | 22.42 | 426.29 | 37.89 |
|
Net Profit Growth (%)
|
-4,335.71 | 25.93 | -6.90 | -25.55 |
|
EPS Growth (%)
|
-2,128.64 | 25.89 | -29.24 | -24.02 |
|
Book Value Growth (%)
|
-57.22 | 12.27 | 24.03 | 4.40 |
Valuation Ratios
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
|
Price / Earnings
|
-2.40 | 14.00 | -0.15 | 16.72 |
|
Price / Book Value
|
1.27 | 2.95 | 0.01 | 1.89 |
|
Dividend Yield (%)
|
-- | -- | -- | -- |
|
EV/EBITDA
|
-5.36 | 8.45 | 1.91 | 12.91 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- |
Solvency Ratios
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
|
Debt to Equity
|
1.23 | 0.47 | 0.79 | 0.34 |
|
Short term debt to equity ratio
|
0.06 | 0.12 | 0.02 | 0.08 |
|
Current Ratio
|
1.04 | 0.89 | 2.40 | 0.71 |
|
Quick Ratio
|
0.88 | 0.67 | 2.38 | 0.65 |
|
Interest Coverage
|
-5.36 | 8.26 | 0.99 | 8.40 |
Operating Efficiency Ratios
| Paramount Skydance Corp Class B | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Walt Disney Company (The) (DIS) | |
|---|---|---|---|---|
|
Debtors to sales (%)
|
20.99 | 26.02 | 31.28 | 14.72 |
|
Asset Turnover
|
0.54 | 0.42 | 0.22 | 0.42 |
|
Receivable days
|
84.61 | 82.12 | 73.28 | 50.18 |
|
Inventory Days
|
27.15 | 203.44 | 3.03 | 12.92 |
|
Payable days
|
17.47 | 496.71 | 130.16 | 92.77 |
|
Cash Conversion Cycle
|
94.30 | -211.15 | -53.86 | -29.67 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
